Cargando…

Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity

The coronavirus disease 2019 (COVID-19) is related to enhanced production of NETs, and autoimmune/autoinflammatory phenomena. We evaluated the proportion of low-density granulocytes (LDG) by flow cytometry, and their capacity to produce NETs was compared with that of conventional neutrophils. NETs a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres-Ruiz, Jiram, Absalón-Aguilar, Abdiel, Nuñez-Aguirre, Miroslava, Pérez-Fragoso, Alfredo, Carrillo-Vázquez, Daniel Alberto, Maravillas-Montero, José Luis, Mejía-Domínguez, Nancy R., Llorente, Luis, Alcalá-Carmona, Beatriz, Lira-Luna, Jaquelin, Núñez-Álvarez, Carlos, Juárez-Vega, Guillermo, Meza-Sánchez, David, Hernández-Gilsoul, Thierry, Tapia-Rodríguez, Miguel, Gómez-Martín, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533917/ https://www.ncbi.nlm.nih.gov/pubmed/34685525 http://dx.doi.org/10.3390/cells10102545

Ejemplares similares

Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study
por: Torres-Ruiz, Jiram, et al.
Publicado: (2022)

Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes
por: Torres-Ruiz, Jiram, et al.
Publicado: (2021)

FANSY POSTCOV: A composite clinical immunological predictive index for post‐COVID‐19 syndrome unveils distinctive features in a cohort study of mild to critical patients
por: Torres‐Ruiz, Jiram, et al.
Publicado: (2021)

Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients
por: Páez-Franco, José C., et al.
Publicado: (2021)

B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients
por: Sosa-Hernández, Víctor A., et al.
Publicado: (2020)

CD11c(+) T-bet(+) CD21(hi) B Cells Are Negatively Associated With Renal Impairment in Systemic Lupus Erythematosus and Act as a Marker for Nephritis Remission
por: Sosa-Hernández, Víctor A., et al.
Publicado: (2022)

The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
por: Chen, Jiezhong, et al.
Publicado: (2020)

Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus
por: Romero-Ramírez, Sandra, et al.
Publicado: (2023)

Conformational changes in myeloperoxidase induced by ubiquitin and NETs containing free ISG15 from systemic lupus erythematosus patients promote a pro-inflammatory cytokine response in CD4(+) T cells
por: Carrillo-Vázquez, Daniel Alberto, et al.
Publicado: (2020)

Effect of polymerised type I collagen on hyperinflammation of adult outpatients with symptomatic COVID‐19
por: Méndez‐Flores, Silvia, et al.
Publicado: (2022)

Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015)

Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology
por: Páez-Franco, José C., et al.
Publicado: (2022)

Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID)
por: Absalón-Aguilar, Abdiel, et al.
Publicado: (2021)

COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps
por: Borges, Leandro, et al.
Publicado: (2020)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

In Vitro Impact of FSH Glycosylation Variants on FSH Receptor-stimulated Signal Transduction and Functional Selectivity
por: Zariñán, Teresa, et al.
Publicado: (2020)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
Publicado: (2020)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
por: -, -
Publicado: (2020)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

Inflammatory myopathies and beyond: The dual role of neutrophils in muscle damage and regeneration
por: Torres-Ruiz, Jiram, et al.
Publicado: (2023)

Current Concepts of Hyperinflammation in Chronic Granulomatous Disease
por: Rieber, Nikolaus, et al.
Publicado: (2012)

COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020)

Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

Hyperinflammation with COVID-19: The key to patient deterioration?()()
por: Haigh, Kathryn, et al.
Publicado: (2020)

Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
por: Taha, Sara Ibrahim, et al.
Publicado: (2022)

Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
por: Shapiro, Leland, et al.
Publicado: (2022)

Fostering experimental and computational synergy to modulate hyperinflammation
por: Potapov, Ilya, et al.
Publicado: (2022)

In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation
por: Li, Xiaoyu, et al.
Publicado: (2023)

Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction
por: Duarte-García, Alí, et al.
Publicado: (2018)

Pulmonary Manifestations of Primary Humoral Deficiencies
por: Casal, Ana, et al.
Publicado: (2022)

Severity of SARS-CoV-2 infection is linked to double-negative (CD27(−) IgD(−)) B cell subset numbers
por: Cervantes-Díaz, Rodrigo, et al.
Publicado: (2021)

Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
por: Garcia-Revilla, Juan, et al.
Publicado: (2020)

Hyperinflammation bei SARS-CoV-2-Infektion
Publicado: (2020)

Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
por: Tanner, Tamara, et al.
Publicado: (2020)

IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020)

Attenuating hyperinflammation in COVID-19: A change in paradigm?
por: Molnar, Zsolt, et al.
Publicado: (2020)

ACEi reduces hypertension-induced hyperinflammation in COVID-19
por: Lim, Gregory B.
Publicado: (2021)

Pseudomonas aeruginosa biofilm is a potent inducer of phagocyte hyperinflammation
por: Ciszek-Lenda, Marta, et al.
Publicado: (2019)

A nanotrap improves survival in severe sepsis by attenuating hyperinflammation
por: Shi, Changying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0p5iarj3gdkvh8b4n75hiqm9o9